Acutaas Chemicals Limited has informed the Exchange about Acquisition
ACUTAAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Acutaas Chemicals Limited is investing up to Rs. 49.99 crores in its wholly-owned subsidiary Acutaas Advance Material Limited (AAML) by subscribing to 30,48,780 equity shares at Rs. 10 face value with a Rs. 154 premium per share through a rights issue. An additional Rs. 150 crores may be invested later via loan, equity, or a mix, in one or more tranches. The first tranche is expected within one month, with further tranches by March 31, 2026. AAML operates in specialty chemicals for the semiconductor industry, currently has a small turnover (Rs. 30 lakhs in FY25), and has entered a joint venture to set up a manufacturing facility in South Korea. Since AAML is already a wholly-owned subsidiary, the transaction will not change Acutaas's shareholding or control. The deal is a related-party transaction done at arm's length based on a registered valuer's report.
This is a capital infusion into the company's existing subsidiary focused on semiconductor-grade specialty chemicals, signaling Acutaas's push into the high-growth semiconductor chemicals space including a South Korea JV. Since the subsidiary is tiny (Rs. 30 lakh turnover), this Rs. 200 crore total potential investment represents a strategic, not financial, move and may be viewed positively by investors betting on the semiconductor chemicals theme.